TY  - JOUR
AU  - Garcia-Doval, I
AU  - Descalzo, M A
AU  - Mason, K J
AU  - Cohen, A D
AU  - Ormerod, A D
AU  - Gómez-García, F J
AU  - Cazzaniga, S
AU  - Feldhamer, I
AU  - Ali, H
AU  - Herrera-Acosta, E
AU  - Griffiths, C E M
AU  - Stern, R S
AU  - Naldi, L
AU  - Psonet Network
PY  - 2018
DO  - 10.1111/bjd.16715
UR  - http://hdl.handle.net/10668/12418
T2  - The British journal of dermatology
AB  - Cancer risk following long-term exposure to systemic immunomodulatory therapies in patients with psoriasis is possible. To assess a dose-response relationship between cumulative length of exposure to biological therapy and risk of cancer. Four...
LA  - en
KW  - Biological Products
KW  - Dermatologic Agents
KW  - Dose-Response Relationship, Drug
KW  - Europe
KW  - Humans
KW  - Immunologic Factors
KW  - Incidence
KW  - Israel
KW  - Neoplasms
KW  - Psoriasis
KW  - Registries
KW  - Time Factors
TI  - Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.
TY  - research article
VL  - 179
ER  -